Board certification in internal medicine and cardiology: Historical success and future challenges

2015 ◽  
Vol 25 (4) ◽  
pp. 305-311 ◽  
Author(s):  
Richard J. Baron ◽  
Harlan M. Krumholz ◽  
Mariell Jessup ◽  
Jennifer L. Brosseau
Keyword(s):  
Internal Medicine ◽  
Board Certification ◽  
Future Challenges

Bereavement

PEDIATRICS ◽  
1992 ◽  
Vol 90 (5) ◽  
pp. 779-780
Author(s):  
WANDA K. PANOSH
Keyword(s):  
Internal Medicine ◽  
Sudden Death ◽  
Board Certification ◽  
Childhood Bereavement ◽  
Grief And Bereavement

To the Editor.— I applaud the Academy's insightful report on "The Pediatrician and Childhood Bereavement."1 Despite training culminating in board certification in Pediatrics and Internal Medicine, I received no effective formal guidance in the area of grief and bereavement. Only since the sudden death of my 7-year-old son and the painful readjustment my family has been forced to undergo since, has it been obvious how deficient we physicians are in this area of caring. Thus I would like to add the following comments:

Association Between Physician Time-Unlimited vs Time-Limited Internal Medicine Board Certification and Ambulatory Patient Care Quality

JAMA ◽  
2014 ◽  
Vol 312 (22) ◽  
pp. 2358 ◽  
Author(s):  
John Hayes ◽  
Jeffrey L. Jackson ◽  
Gail M. McNutt ◽  
Brian J. Hertz ◽  
Jeffrey J. Ryan ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Patient Care ◽  
Care Quality ◽  
Board Certification ◽  
Ambulatory Patient ◽  
Patient Care Quality ◽  
Physician Time

The Diagnosis and Therapy of Helicobacter pylori Infection in Hungary: Comparison of Strategies Applied by Family Physicians and Internists

2019 ◽  
Vol 37 (6) ◽  
pp. 434-443
Author(s):  
Bernadett Márkus ◽  
László Herszényi ◽  
Melinda Matyasovszky ◽  
Krisztián Vörös ◽  
Péter Torzsa ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Helicobacter Pylori ◽  
Eradication Therapy ◽  
Family Physicians ◽  
Helicobacter Pylori Infection ◽  
Board Certification ◽  
The Other ◽  
Second Line ◽  
Sources Of Information ◽  
H Pylori

Background Aims: Most patients with Helicobacter pylori infection are consulted for the first time by family physicians. We aimed to survey the adherence to the newest guidelines of the management of H. pylori infection in the primary and secondary care settings in Hungary. Methods: From a total of 793 physicians, 94 trainees in family medicine, 334 family physicians without and 195 with board certification in internal medicine, 87 internists, 78 family paediatricians were invited to take part in the study. Diagnostic and therapeutic attitudes towards H. pylori infection were compared by a voluntary and anonymous questionnaire. Results: Participants test for H. pylori infection in 92.8% of cases with a family history of peptic ulcer or 76.9% of gastric cancer, 68.9% of dyspepsia and 49.9% of non-specific abdominal complaints, before initiation of non-steroidal anti-inflammatory drug (NSAID; 17.3%) and antiplatelet treatment (14.5%), respectively. They confirm the success of eradication therapy in 88.1% mainly by urea breath test. Most of them initiate eradication therapy by themselves and only 22.4% refer their patients to a gastroenterologist. Clarithromycin-based standard triple therapy is the most preferred (62.1%) and only 3.7% choose quadruple combination with bismuth as first-line and 48.1% as second-line therapy. We found significant differences between groups with respect to the physicians’ own infection, localization of practice, and sources of information on H. pylori infection. Internists are more likely to clarify H. pylori status before the initiation of NSAID and antiplatelet therapies, initiate second-line therapies and use bismuth compared to the other groups. Family physicians with board certification in internal medicine are also prone to start eradication therapy and less prone to refer patients to a gastroenterologist. Family paediatricians prefer stool antigen determination, screen family members and prefer gastroenterologist consultation more often, and use bismuth less frequently than the other groups. Family physicians with previous infection check for H. pyloriinfection more frequently before the initiation of NSAID treatment and are more likely to use histology to detect H. pylori. Postgraduate trainings were the most popular source of information. Conclusion: The adherence to the recent recommendations of current guidelines is moderate. There is a need to increase adherence to current recommendations by family physicians and internists.

scholarly journals Internal medicine board certification and career pathways in Japan

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Soichi Koike ◽  
Masatoshi Matsumoto ◽  
Hiroo Ide ◽  
Hideaki Kawaguchi ◽  
Masahisa Shimpo ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Career Pathways ◽  
Board Certification

scholarly journals Perceptions and attitudes of Small Animal Internal Medicine specialists toward the publication requirement for board certification

2020 ◽  
Vol 34 (2) ◽  
pp. 574-580
Author(s):  
Adam J. Birkenheuer ◽  
Kenneth D. Royal ◽  
Anthony Cerreta ◽  
Daniel Hemstreet ◽  
Katharine F. Lunn ◽  
...  
Keyword(s):  
Internal Medicine ◽  
Small Animal ◽  
Board Certification ◽  
Perceptions And Attitudes

scholarly journals Pneumococcal pneumonia – a history based on chapters from the first edition (1950) and the latest edition (2018) of Harrison’s Principles of Internal Medicine

2021 ◽  
Vol 9 (37) ◽  
pp. 24-31
Author(s):  
Jonathan Kopel ◽  
Ali Hakim ◽  
Kenneth Nugent ◽  
Steven Berk
Keyword(s):  
Internal Medicine ◽  
Bacterial Infections ◽  
Pneumococcal Pneumonia ◽  
Clinical Information ◽  
Resistant Bacteria ◽  
Antibiotic Resistant ◽  
Technological Advances ◽  
Future Challenges ◽  
New Antibiotics ◽  
Historical Developments

Streptococcus pneumoniae remains an important cause of pneumonia-related morbidity and mortality, especially in children and older patients. Although routinely encountered in clinical practice, many clinicians do not know the historical developments in the management of pneumococcal pneumonia and their impact on public health interventions. Reviewing the evolution of clinical information about pneumococcal pneumonia can provide insight into the scientific and technological advances in medicine. Specifically, the development of antibiotics and the development of vaccines against pneumococci were important advances in modern infectious disease control. In addition, the emergence of antibiotic resistant bacteria marks an important development and highlights the need for new antibiotics, antibiotic stewardship, and effective vaccination. To illustrate these ideas, we discuss the evolution of clinical information about pneumococcal pneumonia between the 1st edition (published in 1950) and 20th edition (published in 2018) of Harrison’s Principles of Internal Medicine. This comparison outlines the important advances in the prevention and treatment of pneumonia and provides the background for understanding future challenges in identifying, treating, and preventing bacterial infections, such as pneumococcal pneumonia. Keywords: Pneumococcal pneumonia, Harrison’s Principles of Internal Medicine, antibiotics, vaccination, serotypes

scholarly journals The internist in the surgical setting: results from the Italian FADOI-ER survey

2013 ◽  
pp. 32-38
Author(s):  
Fabio Gilioli ◽  
Carlo Di Donato ◽  
Vincenzo Ferrari ◽  
Marcello Bertesi ◽  
Giuseppe Chesi
Keyword(s):  
Internal Medicine ◽  
Current Knowledge ◽  
Public Healthcare ◽  
Organizational Models ◽  
The Public ◽  
Future Challenges ◽  
Emilia Romagna Region ◽  
Hospital Doctors ◽  
Surgical Setting ◽  
And Training

More and more frequently, patients admitted to surgical wards present characteristics similar to those admitted to medical units. They are fragile patients, often elderly, with significant comorbidity. In recent years, to address these emerging clinical issues in a surgical setting, different organizational models involving specialists of different backgrounds were studied, and in particular involving internists and geriatricians. To widen our current knowledge, in 2011 the Federation of Associations of Hospital Doctors on Internal Medicine of Emilia-Romagna, northern Italy (FADOI-ER), proposed a questionnaire to the public healthcare internal medicine departments of the Emilia Romagna region to collect information as to in what way and to what extent internists are involved in the management of surgical patients. In this article, we analyze the results of the questionnaire and make some organizational considerations and proposals. The questionnaire was very simple, consisting of 14 items. The survey was conducted from 1-28 February 2011. Replies were received from 20 internal medicine departments of a total of 75 in the Emilia Romagna region. The FADOI-ER survey has some limitations, the first of which is that only just under 25% of internal medicine departments in the Emilia Romagna region took part. However, the results are still interesting and seem to suggest that internists, because of their particular cultural background and training, could be the preferred partners for comanagement within the context of inpatient surgical procedures. The results of the FADOI-ER questionnaire are also consistent with the data reported in literature and daily clinical experience that highlight the need for a more multi-specialist approach to patient management with medical internists. Further studies will help provide answers as to the best way to conduct this multidisciplinary approach that could represent one of the future challenges for healthcare.

ACE2 as therapeutic agent

2020 ◽  
Vol 134 (19) ◽  
pp. 2581-2595
Author(s):  
Qiuhong Li ◽  
Maria B. Grant ◽  
Elaine M. Richards ◽  
Mohan K. Raizada
Keyword(s):  
Therapeutic Agent ◽  
Renin Angiotensin System ◽  
Peptide Hormone ◽  
Experimental Models ◽  
Electrolyte Balance ◽  
Ang Ii ◽  
Angiotensin Converting Enzyme 2 ◽  
Beneficial Effects ◽  
Overwhelming Evidence ◽  
Future Challenges

Abstract The angiotensin-converting enzyme 2 (ACE2) has emerged as a critical regulator of the renin–angiotensin system (RAS), which plays important roles in cardiovascular homeostasis by regulating vascular tone, fluid and electrolyte balance. ACE2 functions as a carboxymonopeptidase hydrolyzing the cleavage of a single C-terminal residue from Angiotensin-II (Ang-II), the key peptide hormone of RAS, to form Angiotensin-(1-7) (Ang-(1-7)), which binds to the G-protein–coupled Mas receptor and activates signaling pathways that counteract the pathways activated by Ang-II. ACE2 is expressed in a variety of tissues and overwhelming evidence substantiates the beneficial effects of enhancing ACE2/Ang-(1-7)/Mas axis under many pathological conditions in these tissues in experimental models. This review will provide a succinct overview on current strategies to enhance ACE2 as therapeutic agent, and discuss limitations and future challenges. ACE2 also has other functions, such as acting as a co-factor for amino acid transport and being exploited by the severe acute respiratory syndrome coronaviruses (SARS-CoVs) as cellular entry receptor, the implications of these functions in development of ACE2-based therapeutics will also be discussed.

Sign in / Sign up

Export Citation Format

Share Document